Englert, Crouse Rise Up As Vortex Biosciences Reshuffles Top Team

Vortex Biosciences has announced two promotions within its top executive team, including naming a new CEO.

Vortex Biosciences Inc., which specializes in circulating tumor cell harvesting for cancer diagnostics, has promoted Chief Technology Officer Bob Englert to the role of Chief Executive Officer.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from Medtech Insight

Don’t Sleep On Inspections: Experts Warn FDA Maintains Enforcement Resources

 

Manufacturers of medical products would be foolish to think that recent upheavals at the US FDA will result in a lack of inspections in the coming years. A panel of experts discussed the current state of inspections during a webinar hosted by the Food and Drug Law Institute.

Global Medtech Guidance Tracker: April 2025

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. 25 documents have been posted on the tracker since its last update.

Execs On The Move: 14-18 April 2025

 
• By 

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.